AI2 Incubator spinout Modulus sells cell therapy tech assets to Boston’s Ginkgo Bioworks The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator,… Read More
